Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury [0.03%]
心肌缺血再灌注损伤的新型治疗策略：LAPTM4A促进自噬体-溶酶体融合功能
Siyi Zhou,Jiayi Liu,Manli Hu et al.
Siyi Zhou et al.
Background: Myocardial ischemia-reperfusion (MIR) injury compromises therapeutic effects of revascularization and leads to functional impairment and exacerbation of structural damage in the heart. Limiting the damage caus...
COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34+ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis [0.03%]
COL1A1增强的CD44/SLC7A11相互作用和胱氨酸吸收导致移植动脉粥样硬化中的CD34 +泡沫状巨噬细胞聚集
Junru Wu,Tian He,Mengyao Qi et al.
Junru Wu et al.
Background: Chronic transplant arteriosclerosis is the primary cause of long-term graft failure. Selectively targeting specific inflammatory macrophage subpopulations is essential for inhibiting the primary triggers of in...
Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis [0.03%]
血管平滑肌细胞中冠心病风险基因LMOD1丢失触发快速进展的冠脉动脉粥样硬化
Amr R Salem,Ajay Kumar,Jaser Doja et al.
Amr R Salem et al.
Background: Atherosclerosis is the primary underlying cause of coronary artery disease. LMOD1 is a coronary artery disease risk gene whose role in coronary artery pathophysiology is unknown. Whole-body loss of Lmod1 cause...
Correction to: Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States through 2050: A Scientific Statement from the American Heart Association [0.03%]
对美国女性心血管疾病和卒中的疾病负担预测（至2050年）科学声明的更正：美国心脏协会发布
Karen E Joynt Maddox,Harmony R Reynolds,Demilade Adedinsewo et al.
Karen E Joynt Maddox et al.
Published Erratum
Circulation. 2026 Aug 4;154(5):e233-e234. DOI:10.1161/CIR.0000000000001470 2026
Correction to: 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association [0.03%]
对《2026年心血管疾病和卒中统计报告》的更正——美国心脏协会发布美国及全球数据报告
Latha P Palaniappan,Norrina B Allen,Zaid I Almarzooq et al.
Latha P Palaniappan et al.
Published Erratum
Circulation. 2026 Aug 4;154(5):e231-e232. DOI:10.1161/CIR.0000000000001469 2026
Betty Raman,Sanjay K Prasad
Betty Raman
Response by Fearon et al to Letter Regarding Article, "Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial" [0.03%]
费隆等对“卡维亚尔试验”的来信回复
William F Fearon,Kuniaki Takahashi,Kiran K Khush
William F Fearon
Response by DeRubertis et al to Letter Regarding Article, "Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial" [0.03%]
德鲁伯蒂等关于《药物洗脱可降解支架与球囊成形术治疗膝下外周动脉疾病：LIFE-BTK试验的2年结果》一文的回应
Brian G DeRubertis,Sahil A Parikh,Ramon L Varcoe;LIFE-BTK Investigators
Brian G DeRubertis